Cosette Pharmaceuticals Inc

08/14/2026 | Press release | Archived content

Cosette Pharmaceuticals Acquires Ambien® and Ambien CR® (Zolpidem Tartrate) Tabs from Sanofi US in the US Market

Cosette Pharmaceuticals has received reports of employment scams in recent months that often seek financial and personally identifiable information from job candidates. Unsuspecting job seekers have reported receiving unsolicited contacts from individuals purporting to be or represent Cosette employees. This usually leads to "online interviews" conducted via teleconference applications for virtual positions within the company that do not actually exist. Please be advised that Cosette does not extend unsolicited employment offers and does not utilize chat rooms or ask for financial information during the interview process.

If you would like to pursue employment opportunities with Cosette, please visit our official career website at: www.cosettepharma.com

  • You may report any potential scams to [email protected].
  • You should also report the activity to the Internet Crime Complaint Center at ic3.gov, FTC Fraud Center at www.reportfraud.ftc.gov or your local FBI field office.
  • If you reveal your financial information, contact your financial institution immediately and direct them to stop or reverse the transactions.
  • Ask your financial institution to contact the corresponding financial institution where the fraudulent or suspicious transfer was sent.
Cosette Pharmaceuticals Inc published this content on August 14, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on August 28, 2026 at 14:11 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]